IP Library › Granted Patent US 10,472,659
Granted Patent B2
US 10,472,659 · App. 15/485,689 · Granted Nov 12, 2019

Isothermal nucleic acid amplification

Inventor: Mark Jay Hoser (Broadstairs, GB)
Assignee: GENEFORM TECHNOLOGIES LIMITED
C12P19/34C12Q1/6844
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,472,659
App. No.
15/485,689
Granted
Nov 12, 2019
Kind
B2
Abstract

The present disclosure relates to methods and compositions for ATP regeneration system for use in conjunction with the strand invasion step of an isothermal nucleic acid amplification which uses recombinases that utilize ATP as an energy source.

Claims (13)

1. A method of ATP regeneration in a recombinase enzyme reaction comprising providing to the recombinase enzyme reaction phosphocreatine, creatine kinase, sucrose, and sucrose phosphorylase wherein sucrose and sucrose phosphorylase reacts with accumulated orthophosphate.

2. The method of claim 1 , wherein the recombinase is UvsX.

3. The method of claim 1 , wherein a concentration of 40-100 mM phosphocreatine is used.

4. The method of claim 1 , further comprising providing to the recombinase enzyme reaction a myokinase, wherein AMP is converted to ADP with the myokinase.

5. The method of claim 1 , wherein the reaction further comprises pyrophosphatase to convert pyrophosphate to orthophosphate.

6. The method of claim 1 , wherein ATP regeneration is used in isothermal DNA amplification.

7. A composition for ATP regeneration comprising a recombinase, enzymes which enzymatically convert AMP to ADP or ATP, sucrose and sucrose phosphorylase, and phosphocreatine and creatine kinase.

8. A composition of claim 7 , comprising myokinase.

9. A composition of claim 7 , comprising pyrophosphatase.

10. A composition of claim 7 , wherein the recombinase is UvsX.

11. The method of claim 1 , further comprising providing to the recombinase enzyme reaction one or more energy sources selected from phospho-phenyl-pyruvate and pyruvate kinase; ATP; myokinase; pyrophosphatase; and any combination of two or more of the foregoing.

12. The composition of claim 7 , comprising phospho-phenyl-pyruvate and pyruvate kinase.

13. The composition of claim 7 , comprising ATP.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2018
From: ORION PHARMA (UK) LIMITED
To: GENEFORM TECHNOLOGIES LIMITED
Reel/Frame 045351/0965 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2017
From: HOSER, MARK JAY
To: GENEFORM TECHNOLOGIES LIMITED
Reel/Frame 042224/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2017
From: GENEFORM TECHNOLOGIES LIMITED
To: ORION PHARMA (UK) LIMITED
Reel/Frame 042224/0222 →
Priority Claims (2)
GB 0810650.2 · Jun 11, 2008 · national
GB 0822533.6 · Dec 11, 2008 · national
Continuity (3)
Continuation 14709793 · May 12, 2015
Division 12997382
Related Publication 20170298401A1 · Oct 19, 2017